Nachrichten zur Merck & Co. Inc. Aktie

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Merck To…

2025 March Market Cap Showdown: Andy Cross vs. Matt Argersinger

Its time for another Market Cap Game Show. To catch full episodes of all The Motley Fools free podcasts, check…

Is This Beaten-Down Artificial Intelligence (AI) Stock a Buy?

The artificial intelligence (AI) industry has been on a tear in the past two years, and judging by analyst estimates,…

4 Things You Need to Know if You Buy Recursion Pharmaceuticals Stock Today

Investors looking for an exciting clinical-stage biotech start-up with enormous potential should be paying close attention to Recursion Pharmaceuticals (NASDAQ:…

Merck (MRK) Ascends While Market Falls: Some Facts to Note

Merck (MRK) closed at $94 in the latest trading session, marking a +0.87% move from the prior day.…

Merck (MRK) Up 3.9% Since Last Earnings Report: Can It Continue?

Merck (MRK) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…

KORREKTUR/ROUNDUP 2: Merck will nach Aufschwung weiter profitabel wachsen

(Im letzten Absatz wir klargestellt, dass es sich um rund 70 rpt 70 Standorte handelt.) DARMSTADT (dpa-AFX)…

Boom um Künstliche Intelligenz treibt Merck an

Merck profitiert nicht nur vom Geschäft mit Arzneien, sondern auch vom Hype um Hochleistungschips. Selbst in schwächelnden Bereichen geht es…

DAX: Neues Rekordhoch – DHL Group, Dürr, GFT, Lufthansa, Merck, ProsiebenSat.1, Ströer und Zalando im Check

Der DAX knüpft am Donnerstag an die deutlichen Gewinne vom Vortag an und klettert im frühen Handel einmal mehr auf…

Pharmaindustrie: Pharma und KI-Materialien treiben Merck an – Zuversicht für 2025

Der Dax-Konzern profitiert von starken Geschäften mit Medikamenten und Halbleitermaterialien. Für 2025 rechnet Merck mit weiterem Wachstum – und steht…

Moderna anticipates 2027 release for cancer vaccine in collaboration with Merck By Investing.com

Moderna anticipates 2027 release for cancer vaccine in collaboration with Merck…

Merck & Co., Inc. (MRK) Presents at TD Cowen 45th Annual Health Care Conference (Transcript)

…

These Vanguard ETFs Show Where the Smart Money Is Moving Now

Dont discount the power of momentum. Some studies have found that momentum trading -- buying stocks or exchange-traded funds (ETFs)…

Prediction: 2 Brilliant Vanguard Index Funds Will Continue to Beat the S&P 500 in 2025

The S&P 500 (SNPINDEX: ^GSPC) is widely considered the best gauge for the overall U.S. stock market due to its…

Merck (MRK) Exceeds Market Returns: Some Facts to Consider

Merck (MRK) closed the most recent trading day at $92.25, moving +1.84% from the previous trading session.…

Merck Slips 8% in a Month: Should You Buy, Hold or Sell the Stock?

We believe investors with a long-term horizon should stay invested in MRK stock, while short-term investors should consider selling the…

Can Modernas Aggressive Cost Cuts Help Turn Things Around for Its Stock?

Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future.…

Mercks Oncology Strength: Beating Wall Street Again

…

US drugmaker Merck to boost workforce in India, executive says

Drugmaker Merck , known as MSD outside of the U.S. and Canada, expects to increase its workforce across its India…

US drugmaker Merck to boost workforce in India, executive says By Reuters

US drugmaker Merck to boost workforce in India, executive says…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Edison, Elastic, Intellia, and Merck and Encourages Investors to Contact the Firm

NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Merck expects Keytruda to face HHS price setting in 2026

…

Wall Street Thinks This Weight-Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and Its Not Eli Lilly or Novo Nordisk

Few big pharma stocks have been bigger winners over the last three years than Eli Lilly and Novo Nordisk. Lilly…

MERCK INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - MRK

SAN DIEGO, Feb. 22, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or…

Is Merck Stock a Buy?

Its been a rough start to 2025 for Merck (NYSE: MRK) shareholders following a less-than-stellar fourth-quarter earnings report. Even as…

Why Merck (MRK) is a Great Dividend Stock Right Now

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Dow & Co mit Verlusten - Alibaba, Merck und Hasbro top, Walmart, Bankaktien, Palantir unter ...

An den New Yorker Börsen ist es am Donnerstag mit der Rekordjagd erst einmal vorbei gewesen. Ein unerwartet trüber Ausblick…

Dow & Co mit Verlusten – Alibaba, Merck und Hasbro top, Walmart, Bankaktien, Palantir unter Druck

An den New Yorker Börsen ist es am Donnerstag mit der Rekordjagd erst einmal vorbei gewesen. Ein unerwartet trüber Ausblick…

Dow & Co mit Verlusten – Alibaba, Merck und Hasbro top, Walmart, Bankaktien, Palantir unter Druck

An den New Yorker Börsen ist es am Donnerstag mit der Rekordjagd erst einmal vorbei gewesen. Ein unerwartet trüber Ausblick…

$26.9 Bn Veterinary Vaccines Market Opportunities and Strategies to 2033: Zoetis Leads Highly Concentrated Market (14.21%), Followed by Boehringer Ingelheim, Merck, and Ceva Sante Animale

Dublin, Feb. 19, 2025 (GLOBE NEWSWIRE) -- The "Veterinary Vaccines Market Opportunities and Strategies to 2033" report has…

Merck & Co. Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Filed Against MRK

Robbins LLP is Investigating Allegations that Merck & Co., Inc. (MRK) Misled Investors Regarding the Projected Revenue Outlook and Growth…

Merck HPV vaccine trial linked to HHS Secretary Kennedy postponed

Merck HPV vaccine trial linked to HHS Secretary Kennedy postponed - Reuters…

This Company Just Initiated a Quarterly Dividend: Time to Buy?

Biotech giant Renegeron Pharmaceuticals (NASDAQ: REGN) reported its fourth-quarter and full-year 2024 earnings on Feb. 4. The companys results were…

Merck & Co Aktie: Keytruda-Patentablauf sorgt für Zurückhaltung - Herabstufung!

Frankfurt (www.aktiencheck.de) - Merck & Co-Aktienanalyse von Deutsche Bank: Rating und Kursziel Deutsche Bank-Analyst James Shin hat die die Aktie von Merck…

Pharmaindustrie: Merck stellt Führung neu auf – Healthcare- und Life-Science-Chef wechseln

Der Pharmakonzern erweitert die Geschäftsführung und besetzt Schlüsselpositionen neu. Zusätzlich schafft Merck eine neue Position des Chief People Officer.…

Merck holt neue Leiter für Labor- und Pharmasparte aus eigenen Reihen

DARMSTADT (dpa-AFX) - Personalwechsel im Top-Management bei Merck : Der Darmstädter Dax -Konzern hat drei Manager aus den eigenen Reihen…

JPMorgan belässt Merck KGaA auf Overweight - Ziel 190 Euro

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Merck KGaA anlässlich einiger Änderungen im Top-Management auf…

3 Stocks That Could Trounce the Market in 2025

If youre content with market-level returns, investing in an exchange-traded fund (ETF) is the way to go. But if not,…

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Merck & Co., Inc. (MRK)

NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action…

Medicenna Reports Third Quarter Fiscal 2025 Financial and Operational Results and Provides Anticipated Milestones

- Disease control rate (DCR) of 78% (7 of 9) in combination escalation arm of MDNA11 with Merck’s (known as…

3 Blue-Chip Dividend Stocks Trading at Multiyear Lows

Buying a dividend stock at a cheap valuation can be a great move for several reasons. If a stock has…

Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.

Most companies dont survive for decades, much less pay regular dividends for that long. However, some rare corporations can pull…

Merck Aktie: Gomekli-Zulassung verbessert Verhandlungsposition von SpringWorks

Kulmbach (www.aktiencheck.de) - Merck-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie der Merck KGaA (ISIN: DE0006599905,…

AKTIEN IM FOKUS: Erholung bei Sartorius nach Empfehlung - Merck wieder schwach

FRANKFURT/PARIS (dpa-AFX) - Nach den jüngsten Kurskorrekturen haben sich die Aktien von Sartorius und der Tochter Sartorius Stedim Bio…

DAX vor dem nächsten Tausender – Amadeus Fire, Auto1, Cancom, Ceconomy, LEG Immobilien, Merck, Norma Group, Renk, TUI im Check

Trotz der neuen Trump-Zölle konnte der DAX am gestrigen Montag stark in die Woche starten und mit einem gestrigen Tageshoch…

DAX vor dem nächsten Tausender – Amadeus Fire, Auto1, Cancom, Ceconomy, LEG Immobilien, Merck, Norma Group, Renk, TUI im Check

Trotz der neuen Trump-Zölle konnte der DAX am gestrigen Montag stark in die Woche starten und mit einem gestrigen Tageshoch…

dpa-AFX ProFeed